generally

Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference

October 24, 2025 07:00 ET  | Source: Sagimet Biosciences Inc. Denifanstat met all primary and secondary endpoints versus placebo and…

2 weeks ago

Glac Biotech Secures U.S. Food and Drug Administration GRAS Approval for Probiotic Strain CP-9

TAIPEI, Sept. 15, 2025 /PRNewswire/ -- Glac Biotech, a Taiwan-based developer of probiotics and postbiotics, announced that its core probiotic…

2 months ago

FIS continues commitment to Para events safety and accessibility with annual site visits

Jul 02, 2025 - Every year, generally towards the back end of the season between June and September, FIS organizes an…

4 months ago

Databricks Unveils Lakeflow Designer for Data Analysts to Build Reliable Pipelines Without Coding

New Lakeflow Designer offers drag-and-drop interface to generate production pipelines; Lakeflownow Generally Available SAN FRANCISCO, June 11, 2025 /PRNewswire/ --…

5 months ago